Discover 1,271 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
for
Idiopathic Hypersomnia
Location: Boulder CO, Colorado Springs CO, Ardmore OK, Peoria AZ,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07500090
Phase3, Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Boulder CO, Colorado Springs CO, Peoria AZ, Dallas TX,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07675135
Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Cheyenne WY, Denver CO, Santa Fe NM, Pierre SD,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
for
Cannabis, Memory, Electroencephalography
Location: Boulder CO
Sponsor: L. Cinnamon Bidwell
Sex: All
Age: 21 - 40
Code: NCT07679581
Recruiting
Active & Responsive
Perceptual Influences From Smoking Cannabis: an Experimental Study
for
Cannabis Use, Stress
Location: Boulder CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 21 - 65
Code: NCT06588582
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Cannabidiol and Older Adult Cannabis Users
for
Sleep, Anxiety, Depression, Pain
Location: Boulder CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 60+
Code: NCT06290063
Phase2, Recruiting
Active & Responsive
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
for
Advanced Solid Tumor Cancer,
Location: Boulder CO, Aurora CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 18+
Code: NCT07636200
Recruiting
Active & Responsive
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
for
Edentulism, Tooth Loss
Location: Boulder CO
Sponsor: CeraRoot SL
Sex: All
Age: 18+
Code: NCT06287346
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Thornton CO, Aurora CO, Englewood CO, Rapid City SD,
Data Collection Study Using CS (CardiacSense) BP (Blood Pressure) Watch and Pillow Systems
for
Blood Pressure Monitoring
Location: Louisville CO
Sponsor: CardiacSense Ltd.
Sex: All
Age: 50 - 70+
Code: NCT07749963
Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Aurora CO, Rochester MN, Dallas TX, St Louis MO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase3, Recruiting
Active & Responsive
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
for
Hypertension, Acute Severe Hypertension, Hypertensive Emergency,
Location: Arvada CO, Paris TX, Temple TX, Chicago IL, Laredo TX,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07511361
Phase2, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Wheat Ridge CO, Paradise Valley AZ, Mankato MN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)